PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP

PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP

Jinfeng Wang,1 Song Shang,1 Junjun Li,1 Hongyu Deng,1 Linda Ouyang,1 Hailong Xie,2 Haizhen Zhu,3 Yajun Li,1 Chaohui Zuo1 1Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Laboratory of Digestive Oncology, Affiliated Cancer Hospital of Xiangya...

Full description

Bibliographic Details
Main Authors: Wang J, Shang S, Li J, Deng H, Ouyang L, Xie H, Zhu H, Li Y, Zuo C
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Cancer Management and Research
Subjects:
gdlbcl
r-chop
pd-l1
mir-34a
tumor immunotherapy
Online Access:https://www.dovepress.com/pd-l1-and-mir-34a-are-prognostic-factors-for-primary-gastric-diffuse-l-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/pd-l1-and-mir-34a-are-prognostic-factors-for-primary-gastric-diffuse-l-peer-reviewed-article-CMAR

Similar Items